Clinical role of fludeoxyglucose (18F) positron emission tomography/computed tomography ( 18 F-FDG PET/CT) in patients with pancreatic neuroendocrine tumors
ConclusionAn SUVmax ≥ 2.0 on18F-FDG PET/CT might be associated with higher malignant potential of PNETs.
Source: Surgery Today - Category: Surgery Source Type: research
More News: Brain | Cancer & Oncology | CT Scan | Neurology | Neurosurgery | Pancreas | PET Scan | Study | Surgery